Not available
Quote | MEI Pharma Inc. (NASDAQ:MEIP)
Last: | $2.88 |
---|---|
Change Percent: | 2.49% |
Open: | $2.82 |
Close: | $2.81 |
High: | $2.8891 |
Low: | $2.82 |
Volume: | 6,574 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | MEI Pharma Inc. (NASDAQ:MEIP)
2024-07-01 14:18:31 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Every investment category must answer the big question, why? For undervalued biotech stocks , it comes down to advantaging a supremely relevant sector without paying full price. Of cour...
2024-05-09 17:28:13 ET More on MEI Pharma MEI Pharma shelves plans for a second return of capital Seeking Alpha’s Quant Rating on MEI Pharma Historical earnings data for MEI Pharma Financial information for MEI Pharma Read the full article on...
Message Board Posts | MEI Pharma Inc. (NASDAQ:MEIP)
Subject | By | Source | When |
---|---|---|---|
Out. May recover but R/S concern is | kzivann | investorshub | 12/06/2022 2:46:15 PM |
Doing a little. Risking a part of | kzivann | investorshub | 12/06/2022 12:56:43 PM |
Whats your take on Today thinking if loading | INFINITI | investorshub | 12/06/2022 12:53:43 PM |
Lead drug. FDA issue. Continuing trails in | kzivann | investorshub | 12/06/2022 12:48:06 PM |
Why did it drop so much | INFINITI | investorshub | 12/06/2022 12:42:39 PM |
News, Short Squeeze, Breakout and More Instantly...
-- Ongoing Phase 1 Study Evaluating Voruciclib Plus Venetoclax Demonstrates Anti-leukemic Activity, Including Complete Responses, Anticipated Decreases in Mcl-1 and No Overlapping Toxicity in Heavily Pretreated R/R AML Patients -- -- Board of Directors Unanimously Aligned on Prioritizatio...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital, Prioritizing Measured Investment, Extending Operational Runway – MEI Pharma, Inc. ...